Clinical Trial Update: Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intravitreal VEGF Trap-Eye (aflibercept) for polypoidal choroidal vasculopathy and exudative age-related macular degeneration; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• VEGF Trap-Eye (aflibercept) (aflibercept)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Exudative Age-related Macular Degeneration, Polypoidal Choroidal Vasculopathy | Phase 4 | Status: COMPLETED | Results posted: 2016-04-29